FI944015A - Makrolidien 2-aminosokerijohdannaiset - Google Patents

Makrolidien 2-aminosokerijohdannaiset Download PDF

Info

Publication number
FI944015A
FI944015A FI944015A FI944015A FI944015A FI 944015 A FI944015 A FI 944015A FI 944015 A FI944015 A FI 944015A FI 944015 A FI944015 A FI 944015A FI 944015 A FI944015 A FI 944015A
Authority
FI
Finland
Prior art keywords
pct
macrolides
amino sugar
sugar derivative
group
Prior art date
Application number
FI944015A
Other languages
English (en)
Swedish (sv)
Other versions
FI944015A0 (fi
FI107537B (fi
Inventor
Kevin Koch
Gary R Schulte
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI944015A publication Critical patent/FI944015A/fi
Publication of FI944015A0 publication Critical patent/FI944015A0/fi
Application granted granted Critical
Publication of FI107537B publication Critical patent/FI107537B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI944015A 1992-03-02 1994-09-01 Makrolidien 2-aminosokerijohdannaiset FI107537B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84433992A 1992-03-02 1992-03-02
US84433992 1992-03-02
US9300427 1993-01-27
PCT/US1993/000427 WO1993018048A1 (en) 1992-03-02 1993-01-27 2-aminosugar derivatives of macrolides

Publications (3)

Publication Number Publication Date
FI944015A true FI944015A (fi) 1994-09-01
FI944015A0 FI944015A0 (fi) 1994-09-01
FI107537B FI107537B (fi) 2001-08-31

Family

ID=25292446

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944015A FI107537B (fi) 1992-03-02 1994-09-01 Makrolidien 2-aminosokerijohdannaiset

Country Status (11)

Country Link
US (1) US5631235A (fi)
EP (1) EP0636136B1 (fi)
JP (1) JP2562001B2 (fi)
AT (1) ATE159725T1 (fi)
CA (1) CA2131373C (fi)
DE (1) DE69314947T2 (fi)
DK (1) DK0636136T3 (fi)
ES (1) ES2108261T3 (fi)
FI (1) FI107537B (fi)
GR (1) GR3025672T3 (fi)
WO (1) WO1993018048A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP584198A0 (en) 1998-09-14 1998-10-08 Fujisawa Pharmaceutical Co., Ltd. New use
US7160867B2 (en) 2003-05-16 2007-01-09 Isotechnika, Inc. Rapamycin carbohydrate derivatives
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
AU6286690A (en) * 1989-08-18 1991-04-03 Fisons Plc Macrocyclic compounds
DK0427680T3 (da) * 1989-11-09 1995-12-18 Sandoz Ltd Heteroatom-holdige cykliske forbindelser
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
EP0466365A3 (en) * 1990-07-03 1992-04-15 Merck & Co. Inc. Novel immunosuppressant fermentation products of a microorganism

Also Published As

Publication number Publication date
CA2131373C (en) 1999-01-26
WO1993018048A1 (en) 1993-09-16
DE69314947T2 (de) 1998-03-05
EP0636136B1 (en) 1997-10-29
JP2562001B2 (ja) 1996-12-11
EP0636136A1 (en) 1995-02-01
US5631235A (en) 1997-05-20
DK0636136T3 (da) 1997-12-22
FI944015A0 (fi) 1994-09-01
DE69314947D1 (de) 1997-12-04
GR3025672T3 (en) 1998-03-31
CA2131373A1 (en) 1993-09-16
FI107537B (fi) 2001-08-31
JPH07500350A (ja) 1995-01-12
ATE159725T1 (de) 1997-11-15
ES2108261T3 (es) 1997-12-16

Similar Documents

Publication Publication Date Title
DE69622031T2 (de) INDOLDERIVATE ALS cGMP-PDE INHIBITOREN
DK0597088T3 (da) Nye imidazolderivater, deres fremstilling og terapeutiske anvendelser
FI943805A (fi) Substituoituja adeniinijohdannaisten käyttö multippeliskleroosin hoitoon
DK0509019T3 (da) Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin
EE9800083A (et) Asendatud imidasoolid, millel on vähivastane ja tsütokiine inhibeeriv toime
FI935673A0 (fi) Aminosubstituerade pyrazoler
PT839154E (pt) Peptidos e composicoes biologicamente activos sua utilizacao
NO945034L (no) Derivater i vitamin D-serien modifisert ved 20-stilling, en fremg. for frems. av slike derivater, mellomprodukter anvendt ved fremg., farmasöytiske preparater inneholdende derivatene og deres anvendelse ved frems. av legemidler
DE69231644D1 (de) Verwendung von makrolid-verbindungen gegen augenerkrankungen
ES2160593T3 (es) Desosamino-derivados de microlidos como inmunosupresores y agentes antifungicos.
GR3017128T3 (en) Treatment of hiv infections and compounds useful therein.
ATE34985T1 (de) 1,7-diamino-1,4-dihydro-4-oxo-3-(aza) chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung bakterieller erkrankungen.
SE8107273L (sv) 2-oxoazetidinderivat, sett att framstella democh anvendning derav
TR199801000T2 (xx) Bile�ikler
FI944015A (fi) Makrolidien 2-aminosokerijohdannaiset
CA2132457A1 (en) Fluorosugar Derivatives of Macrolides
EP0774462A4 (en) HETEROCYCLIC COMPOUND
ATE233741T1 (de) Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung
KR880007494A (ko) 5-아릴-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그들의 용도
CA2131372A1 (en) Sugar Derivatives of Macrolides
ES2106567T3 (es) 3-aril-4-alquil y 4,5-dialquil-4h-1,2,4-triazoles utiles como mejoradores de la memoria.
ATE165089T1 (de) Thiocarbamoylverbindungen als mikrobizide
ES8107249A1 (es) Un procedimiento para la preparacion de derivados de 2-epi- fortimicina.
DE69409799T2 (de) Herstellung von symmetrischen und unsymmetrischen disubstituierten n-cyandithioiminocarbonaten
CA2272136A1 (en) Pyrazole derivatives having crf antagonist activity